Campylobacter hominis Lawson et al.
(ATCC® BAA-381D-5™)
Strain Designations Genomic DNA from Campylobacter hominis strain LMG 19568 [ATCC® BAA-381™]
Biosafety Level 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format dried Total DNA: At least 5 μg in 1X TE buffer OD260/OD280: 1.6 to 2.1
Preceptrol® no
Genome Sequenced Strain Campylobacter hominis ATCC BAA-381, complete genome
Type Strain yes
Comments Genome sequenced strain
This preparation of high molecular weight DNA is appropriate for use in the polymerase chain reaction (PCR)
* process and other molecular biology applications.
*the PCR process is covered by patents owned by Hoffmann-La Roche Inc. Use of the PCR process requires a license. Name of Depositor ATCC Special Collection NCRR Contract, DNA
Chain of Custody ATCC <-- BCCM/LMG Laboratory of Microbiology <-- P. Vandamme, Univ. Ghent <-- S. On,
Danish Veter. Lab, Copenhagan, Denmark
References Lawson AJ, et al. Campylobacter hominis sp. nov., from the human gastrointestinal tract. Int. J. Syst. Evol. Microbiol. 51: 651-660, 2001. PubMed: 11321111
Cross References Nucleotide (GenBank) : NC_009714 Campylobacter hominis ATCC BAA-381, complete genome
Nucleotide (GenBank) : CP000775 Campylobacter hominis ATCC BAA-381plasmid pCH4, complete sequence
Nucleotide (GenBank) : AJ251584 Campylobacter hominis partial 16s rRNA gene, strain NCTC 13146
Nucleotide (GenBank) : CP000776 Campylobacter hominis ATCC BAA-381, complete genome.